Login / Signup

The presence of two reduced function variants in CYP2C9 influences the acute response to glipizide.

L ChenJosephine H LiV KaurA MuhammadM FernandezM S HudsonA B GoldfineJ C Florez
Published in: Diabetic medicine : a journal of the British Diabetic Association (2019)
Carriers of two reduced function alleles in CYP2C9 may experience an increased insulin response to glipizide and be predisposed to a higher risk of hypoglycaemia, although no effect of genotype was seen in glucose-based measurements. Further studies are needed to clarify the utility of CYP2C9 genotyping to guide sulfonylurea treatment.
Keyphrases